Protagonist
Protagonist Therapeutics (NASDAQ: PTGX) is consolidating near $144.00 following a pullback from its recent 52-week high of $160.81. The stock continues to hold well above its rising 200-day simple moving average (~$115.80) while compressing near its 50-day moving average (~$143.25), setting up a clean volatility compression structure for a potential swing trade.
Key Trade Parameters & Scenario Analysis
The table below outlines potential execution scenarios, target projections, and estimated hit probabilities based on current support and resistance levels.
| Entry Strategy | Entry Price | Stop Loss | Target 1 (T1) | Target 2 (T2) | T1 Return / Loss | T2 Return / Loss | R:R Ratio (T1 / T2) | T1 Prob. | T2 Prob. |
|---|---|---|---|---|---|---|---|---|---|
| Consolidation Base | $143.50 | $138.50 | $152.00 | $160.80 | +5.92% / -3.48% | +12.06% / -3.48% | 1.7 : 1 / 3.5 : 1 | ~65% | ~40% |
| Trendline Breakout | $147.00 | $141.50 | $158.00 | $168.00 | +7.48% / -3.74% | +14.29% / -3.74% | 2.0 : 1 / 3.8 : 1 | ~55% | ~35% |
| Deep Pullback Re-entry | $136.50 | $131.00 | $146.50 | $160.00 | +7.33% / -4.03% | +17.22% / -4.03% | 1.8 : 1 / 4.3 : 1 | ~70% | ~45% |
Execution Notes & Risk Considerations
- Consolidation Base Entry ($143.50): Captures entry near the 50-day SMA. A break below $138.50 invalidates the immediate setup.
- Trendline Breakout Entry ($147.00): Requires expansion volume clearing $146.50 resistance to confirm momentum toward historical highs.
- Earnings Volatility Warning: Protagonist Therapeutics is scheduled to report earnings around November 5, 2026. Positions held through earnings carry elevated binary risk due to potential gap openings.
Disclaimer
The information provided in this post is for educational and informational purposes only and does not constitute financial, investment, or trading advice. Stock trading involves substantial risk of loss and is not suitable for every investor. Probabilities, price targets, and risk-to-reward metrics are technical estimates and are not guaranteed outcomes. Always conduct your own thorough research, perform independent diligence, and consult with a licensed financial advisor before making any investment decisions.
Comments
Post a Comment